How Managing Pharma Costs Boosts EBITDA
RxBenefits' Peter Lombardi joins GrowthTV
As pharmacy costs at portfolio companies rise, managing that spending is becoming a focal point for private equity firms looking to maximize value. Peter Lombardi, executive advisor for private equity with RxBenefits, joins GrowthTV to discuss how to approach this challenge and mitigate the impact to EBITDA.
This episode is brought to you by RxBenefits, a market-leading pharmacy benefits optimizer.
GrowthTV is produced by the Association for Corporate Growth. To learn more about the organization and how to become a member, visit www.acg.org.
